News : AAICThe Alzheimer

Paris, France -- (July 20, 2011) Quincy Bioscience, a research-based biotechnology company, presented data today which demonstrates an apoaequorin-containing supplement is able to significantly improve cognitive function for adults with memory concerns. The trial findings were shared today in the “Hot Topics” category at the annual Alzheimer’s Association International Conference...

Dogs Demonstrate Jellyfish Protein as a Potential Therapeutic for Memory Disorders at International Conference on Alzheimer’s Disease

Paris, France -- (July 20, 2011) Quincy Animal Health, a leader in canine cognitive health, is pleased to announce that Quincy Animal Health President Mark Underwood presented data today which demonstrates an apoaequorin-containing chewable supplement is able to significantly improve...